Cargando…

Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world

OBJECTIVE: The vaginal ring (ring) is a female-initiated, long-acting drug delivery system for different indications, including HIV prevention. Our aim was to provide evidence for acceptability of the vaginal ring across indications to support dapivirine and multipurpose prevention technology ring i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ridgeway, Kathleen, Montgomery, Elizabeth T., Smith, Kevin, Torjesen, Kristine, van der Straten, Ariane, Achilles, Sharon L., Griffin, Jennifer B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128798/ https://www.ncbi.nlm.nih.gov/pubmed/34644609 http://dx.doi.org/10.1016/j.contraception.2021.10.001

Ejemplares similares

Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis
por: Griffin, Jennifer B., et al.
Publicado: (2019)

Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial
por: Mayo, Ashley J., et al.
Publicado: (2021)

Acceptability of the Dapivirine Vaginal Ring in Postmenopausal US Women
por: Shapley-Quinn, Mary Kate, et al.
Publicado: (2022)

Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring
por: Stoner, Marie C. D., et al.
Publicado: (2022)

Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability
por: Shapley-Quinn, Mary Kate, et al.
Publicado: (2023)

Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa
por: Nel, Annalene, et al.
Publicado: (2016)

Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention
por: Reidy, Meghan, et al.
Publicado: (2019)

Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing(®))
por: Wieder, Devorah R, et al.
Publicado: (2010)

Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP?
por: Bhavaraju, Neeraja, et al.
Publicado: (2021)

The ring plus project: safety and acceptability of vaginal rings that protect women from unintended pregnancy
por: Schurmans, Céline, et al.
Publicado: (2015)

Review of the combined contraceptive vaginal ring, NuvaRing(®)
por: Roumen, Frans JME
Publicado: (2008)

High acceptability of a contraceptive vaginal ring among women in Kigali, Rwanda
por: Kestelyn, Evelyne, et al.
Publicado: (2018)

Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial
por: Palanee-Phillips, Thesla, et al.
Publicado: (2018)

Vaginal rings for delivery of HIV microbicides
por: Malcolm, R Karl, et al.
Publicado: (2012)

Advances in contraception: vaginal contraceptive rings
por: Al-Haddad, Sara, et al.
Publicado: (2023)

The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings
por: Carson, Louise, et al.
Publicado: (2021)

Effects of a One Year Reusable Contraceptive Vaginal Ring on Vaginal Microflora and the Risk of Vaginal Infection: An Open-Label Prospective Evaluation
por: Huang, Yongmei, et al.
Publicado: (2015)

Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial
por: Roberts, Sarah T., et al.
Publicado: (2022)

Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa
por: Leslie, Jonah, et al.
Publicado: (2021)

Association of vaginal dysbiosis and biofilm with contraceptive vaginal ring biomass in African women
por: Hardy, Liselotte, et al.
Publicado: (2017)

Primary vaginal signet ring cell carcinoma
por: Huang, Xiao-Shan, et al.
Publicado: (2022)

Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings
por: Stalter, Randy M, et al.
Publicado: (2016)

Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States
por: Liu, Albert Y, et al.
Publicado: (2021)

Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings
por: Thurman, Andrea Ries, et al.
Publicado: (2019)

Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention
por: Palanee-Phillips, Thesla, et al.
Publicado: (2015)

Color, Scent and Size: Exploring Women's Preferences Around Design Characteristics of Drug-Releasing Vaginal Rings
por: Zhao, Xinyu, et al.
Publicado: (2022)

Acceptability and Satisfaction of Contraceptive Vaginal Rings in Clinical Studies: A Systematic Review and Narrative Synthesis
por: Delvaux, Thérèse, et al.
Publicado: (2021)

A Temperature-Monitoring Vaginal Ring for Measuring Adherence
por: Boyd, Peter, et al.
Publicado: (2015)

Use of simulated vaginal and menstrual fluids to model in vivo discolouration of silicone elastomer vaginal rings
por: McCoy, Clare F., et al.
Publicado: (2021)

Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa
por: van der Straten, Ariane, et al.
Publicado: (2014)

Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls
por: Farr Zuend, Christina, et al.
Publicado: (2021)

Adolescent Girls and Young Women’s Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use: a Multi-Country Qualitative Analysis
por: Young, Alinda M., et al.
Publicado: (2023)

Acute Mesenteric Venous Thrombosis with a Vaginal Contraceptive Ring
por: Eilbert, Wesley, et al.
Publicado: (2014)

An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings
por: MacQueen, Kathleen M, et al.
Publicado: (2014)

Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial
por: Brown, Elizabeth R, et al.
Publicado: (2020)

Acceptability of a Long-Acting, Multipurpose Vaginal Ring: Findings from a Phase I Trial in the U.S. and Dominican Republic
por: Tolley, Elizabeth E., et al.
Publicado: (2022)

Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal Ring
por: Thurman, Andrea R., et al.
Publicado: (2022)

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women
por: Thurman, Andrea Ries, et al.
Publicado: (2018)

Women’s Experiences with Oral and Vaginal Pre-Exposure Prophylaxis: The VOICE-C Qualitative Study in Johannesburg, South Africa
por: van der Straten, Ariane, et al.
Publicado: (2014)

Ring around the chromatin
por: LeBrasseur, Nicole
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_4rdqpe3oq49o89o12ifikfvq21